We are committed to achieving the highest levels of quality.
The senior management team of Alere is comprised of global healthcare leaders with diverse and complementary backgrounds. The team meets regularly and focuses on the key strategic, financial, operational, and policy issues affecting the company.
Chief Executive Officer and President
Namal Nawana was appointed Chief Executive Officer and President and a Member of the Board of Directors... Namal’s career experience has fueled a passionate belief that strategic innovation can achieve better... Before joining Alere, Namal held various global leadership roles during his 15-year tenure at Johnson... Namal was born in Sri Lanka and raised in Australia. He holds an Honors degree in Mechanical Engineering...
Namal Nawana was appointed Chief Executive Officer and President and a Member of the Board of Directors of Alere in October 2014. He joined Alere in December 2012 as Chief Operating Officer to help drive the company to achieve financial strength and operational efficiency.
Namal’s career experience has fueled a passionate belief that strategic innovation can achieve better access, quality and effectiveness of healthcare. In his current role, he is focused on unlocking the full potential of Alere’s assets and leveraging the company’s leadership in rapid diagnostics to develop solutions supporting each of these critical dimensions of healthcare.
Before joining Alere, Namal held various global leadership roles during his 15-year tenure at Johnson & Johnson. He most recently served as Worldwide President of DePuy Synthes Spine, a Johnson & Johnson company. Prior to that role, Namal held general management positions spanning the globe, including Area Vice President for Johnson & Johnson Medical in Australia and New Zealand, Chairman of the DePuy Asia Pacific Franchise Council, General Manager for DePuy Australia and General Manager for DePuy Canada. In these roles, Namal drove continuous growth, innovation and profitability in a variety of specialties and technology fields. He also led diverse scientific and engineering functions as well as commercial operations during the 10-year period he spent living and working in Europe.
Namal was born in Sri Lanka and raised in Australia. He holds an Honors degree in Mechanical Engineering and a Masters of Medical Science degree from the University of Adelaide and an MBA from the Henley Business School in the United Kingdom.
John Bridgen, Ph.D.
Senior Vice President, Business Development
John Bridgen, Ph.D. has served as Senior Vice President, Business Development since July 2010, after...
John Bridgen, Ph.D. has served as Senior Vice President, Business Development since July 2010, after serving as our Vice President, Business Development from June 2006 to July 2010. He served as our Vice President, Strategy from September 2005 to June 2006. Dr. Bridgen joined our Company in September 2002, upon our acquisition of Wampole Laboratories, LLC. Dr. Bridgen served as President of Wampole from August 1984 until September 2005. Prior to joining Wampole, Dr. Bridgen had global sales and marketing responsibility for the hematology and immunology business units of Ortho Diagnostic Systems Inc., a Johnson & Johnson company.
Vice President, General Counsel, Chief Ethics and Compliance Officer, and Secretary
Ellen Chiniara serves as Vice President, General Counsel, Chief Ethics and Compliance Officer, and Secretary...
Ellen Chiniara serves as Vice President, General Counsel, Chief Ethics and Compliance Officer, and Secretary and is responsible for managing legal matters, government affairs and compliance for our Company. Ms. Chiniara joined us in October 2006 as General Counsel, Professional Diagnostics and Assistant Secretary and became our Vice President and General Counsel in May 2007, Secretary in May 2010, and Chief Ethics and Compliance Officer in June 2014. From 2002 to 2006, Ms. Chiniara was Associate General Counsel, Neurology of Serono, Inc., a biopharmaceutical company. Previously, she served as General Counsel to a healthcare venture capital fund and a healthcare management services organization, where she also was Chief Operating Officer of its clinical trial site management division. From 1994 to 1997, Ms. Chiniara was Assistant General Counsel at Value Health, a specialty managed healthcare company where she focused on disease management and healthcare IT. Prior to 1994, Ms. Chiniara was a partner with Hale and Dorr (now Wilmer Hale).
Global President, Cardiometabolic
Daniella Cramp has served as Global President of our cardiometabolic business unit since January 2014...
Daniella Cramp has served as Global President of our cardiometabolic business unit since January 2014. In that role she focuses on cardiovascular and diabetes diagnostics and services across the entire continuum of care from the hospital to the home. From March through December 2013, Ms. Cramp was Global President of Chronic Care. Previously, she served as Vice President of our cardiovascular business unit from September 2007 through March 2013. Ms. Cramp joined Alere in June 2007 upon our acquisition of Biosite, where she had served as director of marketing from 2004 to 2007. Prior to that, Ms. Cramp was the director of Biosite’s physician office segment where she initiated Biosite’s entry into the outpatient setting with its diagnostic platform, Triage. Ms. Cramp also served as the product director for the launch of the Triage BNP Test, the world’s first blood test for heart failure diagnosis. Prior to joining Biosite, Ms. Cramp worked in the pharmaceutical industry for Astra Merck and later AstraZeneca from 1994 to 2000 in various sales and marketing roles supporting cardiovascular and gastrointestinal pharmaceutical products.
Vice President, Operations, North America & EMEA
Mark Gladwell has been Vice President, Operations for North America, Europe, Middle East and Africa ...
Mark Gladwell has been Vice President, Operations for North America, Europe, Middle East and Africa since January 2014. From September 2011 through 2013, he served as Vice President of Operations for North America and as President and General Manager of one of Alere’s key manufacturing facilities in North America. From 2007 to 2010 Mr. Gladwell was Vice President, Quality and Technical Service for Alere. From 2005 to 2007, he served as a director covering multiple functions in the start-up of Alere Technology Limited where he focused on the development and manufacture of the Alere home BNP product. Prior to 2005 Mr. Gladwell held a variety of operations, quality and project leadership positions in North America and Europe for Alere, Johnson & Johnson, Agfa Gavert and DuPont. Mr. Gladwell has more than 18 years of experience in manufacturing high-volume, high-technology in-vitro diagnostics and medical devices.
President, International, and President, Europe and Middle East
Kjersti Grimsrud was appointed President, International and President, Europe and Middle East (EME) ...
Kjersti Grimsrud was appointed President, International and President, Europe and Middle East (EME) for Alere in August 2014. Previously, as Alere’s President, EME, Ms. Grimsrud successfully reorganized the business and established partnerships that drove revenue growth. Ms. Grimsrud has more than 25 years’ experience in the medical diagnostics industry with extensive expertise in sales, marketing, R&D and manufacturing. From 1986 through 2011, she served in a variety of roles at Axis-Shield of Oslo, Norway, including Managing Director, Commercial Director, Marketing Director and Research Scientist. Ms. Grimsrud has built high performing sales organizations through direct and indirect sales channels in more than 80 countries.
Vice President, Global Quality and Regulatory
Melissa Guerdan joined us as Vice President, Global Quality in August 2012. In October 2013, she assumed...
Melissa Guerdan joined us as Vice President, Global Quality in August 2012. In October 2013, she assumed additional responsibility for the Regulatory function and became Vice President, Global Quality and Regulatory. Prior to Alere, Ms. Guerdan was the Vice President of Quality Operations for Covidien’s Pharmaceuticals business from March 2008 to August 2012. In this capacity she was responsible for leading quality and compliance across 11 global manufacturing facilities producing and distributing products ranging from urological imaging systems, contrast media/delivery systems, nuclear medicine products, and specialty generic pharmaceuticals. Prior to that, Ms. Guerdan served as Director of Quality for Baxter’s Renal and Medication Delivery businesses from 2004 to 2008. In addition to these key leadership roles, Ms. Guerdan also held various quality positions at Pfizer and Aventis Behring.
Vice President, Global Human Resources
Robert Hargadon joined us as Vice President, Global Human Resources in October 2010. He has over 30 ...
Robert Hargadon joined us as Vice President, Global Human Resources in October 2010. He has over 30 years of experience in human resources, leadership and organization development. Mr. Hargadon served as Vice President, Human Resources at drugstore.com, an online pharmacy, from November 2006 through October 2010. Prior to that, Mr. Hargadon was General Manager, Corporate Learning and Development at Microsoft from September 2005 to April 2006 and held various human resources leadership positions at Boston Scientific Corporation, a medical device manufacturer, from 1997 to 2005, including Vice President of International Human Resources and Vice President, Leadership Development from September 1997 to June 2005. Mr. Hargadon also served as Vice President, Learning and Development at Fidelity investments from 1993 to 1997. Mr. Hargadon also has 15 years of experience with the consulting firms Novations Group, Inc. and Harbridge House, which was acquired by PricewaterhouseCoopers LLP.
Craig Keyes, M.D.
Global President, Health Information Solutions
Dr. Craig Keyes has served as Global President, Health Information Solutions since August 2013. He joined...
Dr. Craig Keyes has served as Global President, Health Information Solutions since August 2013. He joined the company in March 2011 as Executive Vice President and Chief Medical Officer and served as President of Alere Health since October 2012. A lifelong advocate of health and well-being, Dr. Keyes most recently founded SportXcel, a youth sports performance and adult fitness enterprise in Metro Denver, which provides both commercial and charitable research-based fitness, conditioning and injury-prevention programs for youth, adults, seniors and elite athletes. Prior to SportXcel, Dr. Keyes held senior executive positions over a 10-year span with United Healthcare from 1998-2008, including CEO-New York, CEO-Colorado/New Mexico, National SVP of Mid-Market Sales, and Chief Medical Officer of the 16 markets in the North Division. Dr. Keyes has also held prior positions as a Physician Surveyor for the National Committee for Quality Assurance and as Medical Director for IPRO, a nationally recognized healthcare assessment and improvement organization. Dr. Keyes began his career in the practice of medicine serving under- and un-insured people with HIV/AIDS in New York City.
Global President, Toxicology
Sanjay Malkani has served as Global President, Toxicology since February 2013. Previously, he led our...
Sanjay Malkani has served as Global President, Toxicology since February 2013. Previously, he led our Global Toxicology unit as Vice President and has been directly responsible for the unit’s US and European operations since January 2011. Mr. Malkani joined the Company as Vice President of the Toxicology Strategic Business Unit in February 2008, with responsibility for the Global Toxicology growth strategy and management of the US Toxicology operations. Previously at Roche Diagnostics, Mr. Malkani served as Vice President of Marketing for US Point-of-Care Diagnostics during 2006 to 2007, Vice President of Marketing for US Diabetes Care Hospital in 2005, and held successive sales and marketing roles in the US Diabetes Care business between 2001 and 2005. Prior to 2001, Mr. Malkani held various commercial positions at the Cambridge Group, Inc. and several start-up technology companies. Mr. Malkani completed his MBA at the Kellogg Graduate School of Management, and previously held several sales positions at the Dow Chemical Company, Inc., where he started his career in 1991.
Chief Information Officer
John O’Rourke joined Alere as Chief Information Officer in February 2013. An entrepreneur, Mr. O’Rourke...
John O’Rourke joined Alere as Chief Information Officer in February 2013. An entrepreneur, Mr. O’Rourke has over 24 years of experience running his own businesses, specializing in international information technology and business performance transformation. From April 2001 until February 2010, Mr. O’Rourke was founder and CEO of Catalise PLC and led a variety of significant international engagements with several businesses, including EDF Energy, HP and DPWN/DHL, where he led the creation of the European information technology shared services organization. During this time, Mr. O’Rourke also developed deep expertise in financial shared services, airline restructuring and pre-and-post-acquisition due diligence and integration for major corporations and for private equity. In March 2010, Mr. O’Rourke co-founded his next venture, Genysys Ltd, where he continued to provide M&A advisory services to large corporations, such as DSM Life Sciences, Nokia and The Energy Saving Trust.
Global President, Infectious Disease
Avi Pelossof was appointed Global President of our Infectious Disease business unit in March 2013, after...
Avi Pelossof was appointed Global President of our Infectious Disease business unit in March 2013, after serving as Vice President of that business from February 2008 to February 2013. In August 2014, Mr. Pelosoff assumed additional responsibilities for Alere in Africa and Latin America. Mr. Pelossof joined Alere as Vice President, Blood-Borne Pathogens in January 2007 and served in that role until January 2008. Mr. Pelossof has more than 20 years of experience in diagnostics, global health and international finance, including senior roles at Chembio Diagnostic Systems, a manufacturer of diagnostic tests for infectious diseases, and Citigroup.
President, No. American Commercial Operations
Peter Scheu has served as President, North American Commercial Operations, since January 2014. Mr. Scheu...
Peter Scheu has served as President, North American Commercial Operations, since January 2014. Mr. Scheu joined Alere in March 2007 and most recently led sales and marketing for Alere’s Physician Diagnostics Group. Prior to Alere, Mr. Scheu held various management positions at Apogent Technologies, which was acquired by Fisher in 2004. During his 9 years at Apogent and Fisher, he integrated and consolidated multiple businesses and spearheaded significant revenue growth. In his last position at Apogent, he was Group President with responsibility for five divisions – Immunodiagnostics, Anatomic Pathology, Immunohistochemistry, Microbiology and OEM. Before Apogent, Mr. Scheu served in a number of sales and marketing positions at Baxter Healthcare.
Chief Financial Officer, Vice President and Treasurer
David Teitel has served as our Chief Financial Officer, Vice President and Treasurer since December ...
David Teitel has served as our Chief Financial Officer, Vice President and Treasurer since December 2006. Mr. Teitel has over 25 years of public and private company finance experience, including nine years of audit experience at Arthur Andersen and senior financial positions with Thermo Electron Corp., which is now Thermo Fisher Scientific Inc. and Deknatel Snowden Pencer, Inc. Mr. Teitel joined the Company in December 2003 as Director of Finance Operations and assumed the title Vice President, Finance in December 2004.